This session included five presentations in the areas of pathology of precu
rsor lesions and carcinoma of the prostate, the value of determining neovas
cularity in the diagnosis and staging of prostate cancer, new 'molecular' m
arkers, correlation between pre- and postoperative Gleason scores and a stu
dy dealing with transition zone PSA density. The abstracts and talks are su
mmarized in the next few pages.